BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7905717)

  • 1. Glibenclamide prevents coronary vasodilation induced by beta 1-adrenoceptor stimulation in dogs.
    Narishige T; Egashira K; Akatsuka Y; Imamura Y; Takahashi T; Kasuya H; Takeshita A
    Am J Physiol; 1994 Jan; 266(1 Pt 2):H84-92. PubMed ID: 7905717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP-sensitive K+ channel opener pinacidil augments beta 1-adrenoceptor-induced coronary vasodilation in dogs.
    Katsuda Y; Egashira K; Ueno H; Arai Y; Akatsuka Y; Kuga T; Shimokawa H; Takeshita A
    Am J Physiol; 1996 Jun; 270(6 Pt 2):H2210-5. PubMed ID: 8764276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and coronary vasodilative properties of a selective and full beta 1-adrenoceptor agonist, T-0509, in comparison with isoproterenol in anesthesized dogs.
    Yamazaki J; Sugimoto T; Yabana H; Nagao T
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):209-15. PubMed ID: 7526052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of adenosine triphosphate-sensitive potassium channels eliminates isoflurane-induced coronary artery vasodilation.
    Cason BA; Shubayev I; Hickey RF
    Anesthesiology; 1994 Nov; 81(5):1245-55; discussion 27A-28A. PubMed ID: 7978484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of ATP-sensitive potassium channels in beta 2-adrenoceptor agonist-induced vasodilatation on rat diaphragmatic microcirculation.
    Chang HY
    Br J Pharmacol; 1997 Jul; 121(5):1024-30. PubMed ID: 9222563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade.
    Duncker DJ; van Zon NS; Pavek TJ; Herrlinger SK; Bache RJ
    J Clin Invest; 1995 Jan; 95(1):285-95. PubMed ID: 7814627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glibenclamide decreases basal coronary blood flow in anesthetized dogs.
    Imamura Y; Tomoike H; Narishige T; Takahashi T; Kasuya H; Takeshita A
    Am J Physiol; 1992 Aug; 263(2 Pt 2):H399-404. PubMed ID: 1510137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 2-adrenergic dilation of resistance coronary vessels involves KATP channels and nitric oxide in conscious dogs.
    Ming Z; Parent R; Lavallée M
    Circulation; 1997 Mar; 95(6):1568-76. PubMed ID: 9118527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of K+ATP channels in local metabolic coronary vasodilation.
    Richmond KN; Tune JD; Gorman MW; Feigl EO
    Am J Physiol; 1999 Dec; 277(6):H2115-23. PubMed ID: 10600828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of K+ ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow.
    Duncker DJ; van Zon NS; Ishibashi Y; Bache RJ
    J Clin Invest; 1996 Feb; 97(4):996-1009. PubMed ID: 8613554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glibenclamide, a selective inhibitor of ATP-sensitive K+ channels, attenuates metabolic coronary vasodilatation induced by pacing tachycardia in dogs.
    Katsuda Y; Egashira K; Ueno H; Akatsuka Y; Narishige T; Arai Y; Takayanagi T; Shimokawa H; Takeshita A
    Circulation; 1995 Aug; 92(3):511-7. PubMed ID: 7634466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of K+ATP channel and adenosine receptor blockade during rest and exercise in congestive heart failure.
    Traverse JH; Chen Y; Hou M; Li Y; Bache RJ
    Circ Res; 2007 Jun; 100(11):1643-9. PubMed ID: 17478726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glibenclamide, a putative ATP-sensitive K+ channel blocker, inhibits coronary autoregulation in anesthetized dogs.
    Narishige T; Egashira K; Akatsuka Y; Katsuda Y; Numaguchi K; Sakata M; Takeshita A
    Circ Res; 1993 Oct; 73(4):771-6. PubMed ID: 8370126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glibenclamide-induced oscillation of canine coronary artery is independent of myocardial ischemia.
    Nakae I; Quan L; Sugimoto Y; Tsutamoto T; Kinoshita M
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):473-9. PubMed ID: 7515993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ATP-sensitive potassium channel inhibition on coronary metabolic vasodilation in humans.
    Farouque HM; Worthley SG; Meredith IT
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):905-10. PubMed ID: 15016638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in in situ canine hearts.
    Crystal GJ; Zhou X; Gurevicius J; Ramez Salem M
    Anesth Analg; 1998 Nov; 87(5):994-1001. PubMed ID: 9806671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog.
    Akatsuka Y; Egashira K; Katsuda Y; Narishige T; Ueno H; Shimokawa H; Takeshita A
    Cardiovasc Res; 1994 Jun; 28(6):906-11. PubMed ID: 7923297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of K+ATP channels in coronary vasodilation during exercise.
    Duncker DJ; Van Zon NS; Altman JD; Pavek TJ; Bache RJ
    Circulation; 1993 Sep; 88(3):1245-53. PubMed ID: 8353886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP sensitive K(+) channels are critical for maintaining myocardial perfusion and high energy phosphates in the failing heart.
    Jameel MN; Xiong Q; Mansoor A; Bache RJ; Zhang J
    J Mol Cell Cardiol; 2016 Mar; 92():116-21. PubMed ID: 26854629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
    Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.